Tarabios

Tarabios is a med-tech company founded in 2020 and headquartered in Germany. The company is dedicated to developing a mobile device aimed at monitoring blood clot times (PT/INR) specifically for Warfarin Therapy patients. This innovative technology utilizes a patented mechanical measurement system, capable of assessing blood viscosity on a cartridge with microfluidic channels. Tarabios has recently secured $3.50M in Seed Round investment on 02 July 2021, with the investment coming from Inventram. The company's vision extends beyond their initial product, as they plan to further develop the platform technology to enable multiplexed, low-cost, and user-friendly point-of-need tests for numerous other diseases. With its focus on revolutionizing blood diagnostics and aspirations for expansion into various healthcare sectors, Tarabios presents an intriguing investment opportunity within the Health Care industry.